Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

75.0%

3 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05330897Not ApplicableActive Not Recruiting

French eCLIPs™ Efficacy and Safety Investigation

Role: lead

NCT02607501Not ApplicableTerminated

European eCLIPS™ Safety, Feasibility and Efficacy Study

Role: lead

NCT04886505Not ApplicableWithdrawn

An EFS Assessing the Electrolytic eCLIPs System for Treatment of Intracranial Aneurysms

Role: lead

NCT01957683Phase 1Withdrawn

Canadian eCLIPs™ Safety and Feasibility Study Protocol

Role: lead

All 4 trials loaded